Immunology

Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That’s why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.

Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.

Early in his career Daniel Cua, Ph.D., made a discovery that would lead to a new medication for the debilitating autoimmune disease. We sat down with Dr. Cua, known as “the father” in his field of study, to learn what his work could mean for those with psoriatic arthritis.

A groundbreaking trial for an HIV vaccine. New ways to help the body heal itself. Immunotherapy treatments for cancer. Behind medical advancements like these are the brilliant scientists who are relentlessly pushing their visions and research forward.

We sat down with the winner of the 2018 Dr. Paul Janssen Award for Biomedical Research to learn how his tireless cancer research efforts have helped revolutionize the way we treat the disease—and save lives.

Tackling a triathlon isn’t for the faint of heart. But Mark van Ooij, an Associate Scientific Director for Janssen Vaccines & Prevention B.V., is doing just that—and he’s taking what he’s learned from his disease to propel him forward.

An avid runner. A fireman. A college student. What they share in common may surprise you—and the battle to get their lives back after debilitating diagnoses will inspire you.